Alan Bernard Fleischer Jr. , MD

Bachelor of Arts: University of Missouri-Columbia Columbia, MO, 1982

MD: University of Missouri-Columbia Columbia, MO, 1987 (Medicine)

Residency: University of North Carolina Chapel Hill, NC, 1988 (Internal Medicine)

Residency: University of North Carolina Chapel Hill, NC, 1991 (Dermatology)

American Board of Dermatology (Certification Date: 11-04-1991 ) - (Recertification Date: to 01-01-2022 )

Dermatology

Acne (Blackheads)

Actinic Keratosis (Solar Keratosis)

Eczema (Atopic Dermatitis)

Hidradenitis Suppurativa

Moles

Pruritus (Itchy skin)

Psoriasis

Urticaria (Hives and angioedema)

Dermatology

Hidradenitis Suppurativa, General Dermatology

Grant: #22158 Investigators:Fleischer, Alan 01-27-2023 -01-26-2026 IQVIA Clinical Trial Payments A randomized, placebo-controlled, double-blind, parallel-group, multicenter Phase 2a study to investigate efficacy and safety of zabedosertib (BAY 1834845) for the treatment of adult patients with mod Role:PI 302227.00 Active Level:Industry

Grant: #2022-0795 Investigators:Fleischer, Alan 04-18-2023 -04-17-2026 IQVIA Clinical Trial Payments A TWO-PART, MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL DIFELIKEFALIN AS ADJUNCT THERAPY TO A TOPICAL CORTICOSTEROID FOR MODERATE-TO-SEVERE PRURITUS IN ADUL Role:PI 0.00 Hold Level:Industry

Grant: #20210143 Investigators:Fleischer, Alan 06-02-2023 -06-30-2025 Amgen, Inc A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Role:PI 286339.85 Active Level:Industry

Investigators:Fleischer, Alan 01-23-2023 -01-22-2028 Bayer AG Master Clinical Trial Agreement Role:PI 0.00 Hold Level:Industry

Grant: #INCB 18424-319 Investigators:Fleischer, Alan 11-15-2023 -11-15-2026 Incyte Corporation A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis Role:PI 364125.00 Hold Level:Industry

Investigators:Fleischer, Alan 01-17-2024 -01-17-2027 Inmagene LLC A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis Role:PI 341718.20 Hold Level:Industry

Grant: #LP0145-2240-A phase 2b Investigators:Fleischer, Alan 03-08-2024 -03-08-2027 LEO Pharma LP0145-2240-A phase 2b, randomized, double-blind, placebo-controlled, multi-site,parallel-group, dose-finding trial to evaluate the efficacy and safety of different doses of subcutaneously administere Role:PI 389988.89 Hold Level:Industry

Grant: #INCB 54707-312 STOP-HS LTE Investigators:Fleischer, Alan 05-02-2024 -05-01-2027 IQVIA Clinical Trial Payments A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa Role:PI 213896.89 Hold Level:Industry

Grant: #CDX0159-10 Investigators:Fleischer, Alan 07-12-2024 -07-11-2027 Celldex Therapeutics, Inc. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients with Prurigo Nodularis Role:PI 0.00 Hold Level:Industry

Peer Reviewed Publications

He, Alice; Feldman, Steven R; Fleischer, Alan B (2018. ) Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012. Journal of drugs in dermatology : JDD, , 17 (2 ) ,135-140

Wetzel, Margaret E; Fleischer, Alan B (2017. ) Factors affecting the rise of treatment of resistant bacteria in skin and soft tissue infections in the United States: 1993-2012.The Journal of dermatological treatment, , 28 (5 ) ,417-421 More Information

Udechukwu, Nneka S; Fleischer, Alan B Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United States.Journal of the National Medical Association, , 109 (1 ) ,44-48 More Information

Austin, Brett A; Fleischer, Alan B (2017. ) The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.The Journal of dermatological treatment, , 28 (2 ) ,145-148 More Information

Fleischer, Alan B (2017. ) Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians.The Journal of dermatological treatment, , 28 (2 ) ,181-185 More Information

Pongcharoen, P; Fleischer, A B (2016. ) An evidence-based review of systemic treatments for itch.European journal of pain (London, England), , 20 (1 ) ,24-31 More Information

Abokwidir, Manal; Fleischer, Alan B (2015. ) Additional evidence that rosacea pathogenesis may involve demodex: new information from the topical efficacy of ivermectin and praziquantel. Dermatology online journal, , 21 (9 ) ,

Abokwidir, Manal; Fleischer, Alan B (2015. ) An emerging treatment: Topical ivermectin for papulopustular rosacea.The Journal of dermatological treatment, , 26 (4 ) ,379-80 More Information

Kannangara, Ajith P; Yosipovitch, Gil; Fleischer, Alan B (2014. ) Proposed classification for Koebner, Wolf isotopic, Renbok, Koebner nonreaction, isotopic nonreaction and other related phenomen. Dermatology online journal, , 20 (11 ) ,

Shaw, Matthew K; Davis, Scott A; Fleischer, Alan B; Feldman, Steven R (2014. ) The duration of office visits in the United States, 1993 to 2010. The American journal of managed care, , 20 (10 ) ,820-6

Shaw, Meredith K; Davis, Scott A; Feldman, Steven R; Fleischer, Alan B (2014. ) Trends in systemic psoriasis treatment therapies from 1993 through 2010. Journal of drugs in dermatology : JDD, , 13 (8 ) ,917-20

Fleischer, A B (1993. ) Pruritus in the elderly: management by senior dermatologists. Journal of the American Academy of Dermatology, , 28 (4 ) ,603-9

Aslam, Imran; Fleischer, Alan; Feldman, Steve (2015. ) Emerging drugs for the treatment of acne.Expert opinion on emerging drugs, , 20 (1 ) ,91-101 More Information

Stein, Linda; Kircik, Leon; Fowler, Joseph; Tan, Jerry; Draelos, Zoe; Fleischer, Alan; Appell, Melanie; Steinhoff, Martin; Lynde, Charles; Liu, Hong; Jacovella, Jean (2014. ) Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies. Journal of drugs in dermatology : JDD, , 13 (3 ) ,316-23

McGregor, Sean P; Alinia, Hossein; Snyder, Alyson; Tuchayi, Sara Moradi; Fleischer, Alan; Feldman, Steven R (2018. ) A Review of the Current Modalities for the Treatment of Papulopustular Rosacea.Dermatologic clinics, , 36 (2 ) ,135-150 More Information

Taheri, Arash; Davis, Scott A; Huang, Karen E; Feldman, Steven R (2015. ) Onychomycosis treatment in the United States. Cutis, , 95 (5 ) ,E15-21

Kuo, Sandy; Huang, Karen E; Davis, Scott A; Feldman, Steven R (2015. ) The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis, , 95 (1 ) ,37-43

O'Neill, Jenna L; Shutty, Brandon; Sun Lee, Yun; Solomon, James A; Patel, Nikita; Davis, Scott A; Taheri, Arash; Huang, Karen E; Landis, Erin T; Robins, Douglas N; Williford, Philip M; Feldman, Steven R; Pearce, Daniel J (2014. ) Comparing demographic characteristics and adverse event rates at two dermatologic surgery practices.Journal of cutaneous medicine and surgery, , 18 (5 ) ,337-40 More Information

Hartel, Jennifer; Huang, Karen E; Taheri, Arash; Sandoval, Laura F; Davis, Scott A; Feldman, Steven R; Huang, William W (2014. ) Are patients willing to participate in surveys?.The Journal of dermatological treatment, , 25 (5 ) ,365-6 More Information

Huang, Karen E; Davis, Scott A; Cantrell, Jacob; Feldman, Scott R (2014. ) Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditions. Dermatology online journal, , 20 (9 ) ,

Sandoval, Laura F; Huang, Karen E; Davis, Scott A; Feldman, Steven R; Taylor, Sarah L (2014. ) Trends in the Use of Neurotoxins and Dermal Fillers by US Physicians. The Journal of clinical and aesthetic dermatology, , 7 (9 ) ,14-9

Huang, Karen E; Milliron, Brandy-Joe; Davis, Scott A; Feldman, Steven R (2014. ) Surge in US outpatient vitamin D deficiency diagnoses: National Ambulatory Medical Care Survey analysis.Southern medical journal, , 107 (4 ) ,214-7 More Information

Mireku, Kenyatta; Huang, Karen E; Narahari, Swetha; Davis, Scott A; Feldman, Steven R (2013. ) Psoriasis treatments by payment type in the US outpatient office setting. Journal of drugs in dermatology : JDD, , 12 (10 ) ,1095-7

Lin, Hsien-Chang; Alamdari, Habibollah S; Huang, Karen E; Gustafson, Cheryl J; Davis, Scott A; Balkrishnan, Rajesh; Feldman, Steven R Prevalence of psoriasis and rosacea comorbidities in the outpatient setting.Journal of cutaneous medicine and surgery, , 17 (5 ) ,295-8 More Information